BackAnxo Pharmaceutical , Ltd. Overview

Anxo Pharmaceutical , Ltd. Total Liabilities

Track Anxo Pharmaceutical , Ltd.'s total liabilities ($980M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$978.62M
↑ 5.01% YoYΔ $46.66M vs prior year quarter

Peer trimmed avg / median

Loading

Anxo Pharmaceutical , Ltd. Total Liabilities History

Loading

Anxo Pharmaceutical , Ltd. vs. peers: Total Liabilities Comparison

Loading

Anxo Pharmaceutical , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anxo Pharmaceutical , Ltd. (6677.TWO) FAQ

As of the most recent data (June 2026), 6677.TWO shows a total liabilities of $980M. That compares with $930M in the prior-year period — up 5.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6677.TWO's total liabilities is now $980M (was $930M) — a 5.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Anxo Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 6677.TWO's total liabilities over time shows whether Anxo Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $980M That compares with $930M in the prior-year period — up 5.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Anxo Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $980M) with ownership activity and broader fundamentals.